

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 5.38107005 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 4.99562311 |
| 3 | angiotensin maturation (GO:0002003) | 4.57356743 |
| 4 | postsynaptic membrane organization (GO:0001941) | 4.06060457 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 3.92500779 |
| 6 | desmosome organization (GO:0002934) | 3.80706697 |
| 7 | vitamin A metabolic process (GO:0006776) | 3.70033168 |
| 8 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.64702203 |
| 9 | cell differentiation involved in metanephros development (GO:0072202) | 3.58677736 |
| 10 | positive regulation of pseudopodium assembly (GO:0031274) | 3.55867416 |
| 11 | GDP-mannose metabolic process (GO:0019673) | 3.51651775 |
| 12 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.51306746 |
| 13 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.42687325 |
| 14 | renal system process involved in regulation of blood volume (GO:0001977) | 3.42047884 |
| 15 | facial nerve structural organization (GO:0021612) | 3.34698670 |
| 16 | respiratory chain complex IV assembly (GO:0008535) | 3.34391525 |
| 17 | protein retention in ER lumen (GO:0006621) | 3.33936932 |
| 18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.33622470 |
| 19 | regulation of pseudopodium assembly (GO:0031272) | 3.33563633 |
| 20 | epithelial cell-cell adhesion (GO:0090136) | 3.26633285 |
| 21 | sodium ion export (GO:0071436) | 3.25705918 |
| 22 | peptide hormone processing (GO:0016486) | 3.21734865 |
| 23 | hemidesmosome assembly (GO:0031581) | 3.20545495 |
| 24 | glandular epithelial cell differentiation (GO:0002067) | 3.20395879 |
| 25 | renal filtration (GO:0097205) | 3.20027906 |
| 26 | fructose metabolic process (GO:0006000) | 3.15912637 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 3.14815444 |
| 28 | COPI coating of Golgi vesicle (GO:0048205) | 3.14815444 |
| 29 | negative regulation of fatty acid transport (GO:2000192) | 3.11435816 |
| 30 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.10700001 |
| 31 | negative regulation of hormone metabolic process (GO:0032351) | 3.09584002 |
| 32 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.09584002 |
| 33 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.06240608 |
| 34 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.99960216 |
| 35 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.95405457 |
| 36 | regulation of bile acid biosynthetic process (GO:0070857) | 2.94181693 |
| 37 | actin filament depolymerization (GO:0030042) | 2.92571906 |
| 38 | hormone catabolic process (GO:0042447) | 2.91455248 |
| 39 | glomerular filtration (GO:0003094) | 2.90619987 |
| 40 | lipoprotein transport (GO:0042953) | 2.90559124 |
| 41 | glucose 6-phosphate metabolic process (GO:0051156) | 2.89632503 |
| 42 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.84755958 |
| 43 | regulation of cholesterol homeostasis (GO:2000188) | 2.83803956 |
| 44 | proline biosynthetic process (GO:0006561) | 2.82999122 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 2.81818093 |
| 46 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.81155893 |
| 47 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.80988697 |
| 48 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.80988697 |
| 49 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79538530 |
| 50 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.78792071 |
| 51 | barbed-end actin filament capping (GO:0051016) | 2.77535590 |
| 52 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.77518558 |
| 53 | regulation of extracellular matrix disassembly (GO:0010715) | 2.75500986 |
| 54 | renal absorption (GO:0070293) | 2.73449182 |
| 55 | cell-substrate junction assembly (GO:0007044) | 2.72339083 |
| 56 | response to hepatocyte growth factor (GO:0035728) | 2.71924657 |
| 57 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.71924657 |
| 58 | diacylglycerol metabolic process (GO:0046339) | 2.71602917 |
| 59 | adherens junction assembly (GO:0034333) | 2.71530308 |
| 60 | neuronal action potential propagation (GO:0019227) | 2.70311370 |
| 61 | virion attachment to host cell (GO:0019062) | 2.70252739 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 2.70252739 |
| 63 | urea cycle (GO:0000050) | 2.70080131 |
| 64 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.69695301 |
| 65 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.68456786 |
| 66 | metanephric tubule development (GO:0072170) | 2.68250440 |
| 67 | metanephric nephron tubule development (GO:0072234) | 2.68250440 |
| 68 | regulation of male gonad development (GO:2000018) | 2.65480885 |
| 69 | receptor recycling (GO:0001881) | 2.65215628 |
| 70 | mesonephros development (GO:0001823) | 2.63697177 |
| 71 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.63585903 |
| 72 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.63585903 |
| 73 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.62534095 |
| 74 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.61989298 |
| 75 | skin morphogenesis (GO:0043589) | 2.60477566 |
| 76 | presynaptic membrane assembly (GO:0097105) | 2.59743836 |
| 77 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.58978138 |
| 78 | cell communication involved in cardiac conduction (GO:0086065) | 2.58018293 |
| 79 | endothelium development (GO:0003158) | 2.57931442 |
| 80 | pattern specification involved in kidney development (GO:0061004) | 2.57055275 |
| 81 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.56247316 |
| 82 | negative regulation of myotube differentiation (GO:0010832) | 2.54936543 |
| 83 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.54575221 |
| 84 | cGMP-mediated signaling (GO:0019934) | 2.53923262 |
| 85 | nephron tubule formation (GO:0072079) | 2.53851407 |
| 86 | protein localization to endosome (GO:0036010) | 2.53528879 |
| 87 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.53463576 |
| 88 | basement membrane organization (GO:0071711) | 2.53191547 |
| 89 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.52407556 |
| 90 | digestive system process (GO:0022600) | 2.51352061 |
| 91 | cellular potassium ion homeostasis (GO:0030007) | 2.50729348 |
| 92 | cell-substrate adherens junction assembly (GO:0007045) | 2.50329820 |
| 93 | focal adhesion assembly (GO:0048041) | 2.50329820 |
| 94 | negative regulation of catenin import into nucleus (GO:0035414) | 2.50262076 |
| 95 | urea metabolic process (GO:0019627) | 2.49604356 |
| 96 | phospholipid scrambling (GO:0017121) | 2.49158651 |
| 97 | vocalization behavior (GO:0071625) | 2.48545853 |
| 98 | cerebellar Purkinje cell layer development (GO:0021680) | 2.48442357 |
| 99 | cytochrome complex assembly (GO:0017004) | 2.48285599 |
| 100 | cellular response to nutrient (GO:0031670) | 2.48263663 |
| 101 | androgen biosynthetic process (GO:0006702) | 2.47638788 |
| 102 | semaphorin-plexin signaling pathway (GO:0071526) | 2.47027570 |
| 103 | metanephric epithelium development (GO:0072207) | 2.46689381 |
| 104 | vitamin transmembrane transport (GO:0035461) | 2.45576253 |
| 105 | nucleoside diphosphate catabolic process (GO:0009134) | 2.44791204 |
| 106 | actin filament capping (GO:0051693) | 2.44761400 |
| 107 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.43877836 |
| 108 | digestion (GO:0007586) | 2.43808565 |
| 109 | keratan sulfate biosynthetic process (GO:0018146) | 2.43518069 |
| 110 | cell-cell junction maintenance (GO:0045217) | 2.43480052 |
| 111 | flavonoid metabolic process (GO:0009812) | 2.41528828 |
| 112 | regulation of hormone metabolic process (GO:0032350) | 2.41442093 |
| 113 | protein heterotrimerization (GO:0070208) | 2.41353661 |
| 114 | activation of Rac GTPase activity (GO:0032863) | 2.40607158 |
| 115 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.40188404 |
| 116 | regulation of axon guidance (GO:1902667) | 2.39881840 |
| 117 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.39624486 |
| 118 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.39556891 |
| 119 | adhesion of symbiont to host (GO:0044406) | 2.39356929 |
| 120 | regulation of cGMP biosynthetic process (GO:0030826) | 2.37858561 |
| 121 | metanephric nephron epithelium development (GO:0072243) | 2.37775816 |
| 122 | proline metabolic process (GO:0006560) | 2.36938864 |
| 123 | endothelial cell chemotaxis (GO:0035767) | 2.36495477 |
| 124 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.36493516 |
| 125 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.36493516 |
| 126 | endocrine process (GO:0050886) | 2.36493516 |
| 127 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.36377649 |
| 128 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.35436668 |
| 129 | negative regulation of actin filament depolymerization (GO:0030835) | 2.35353346 |
| 130 | cell communication by electrical coupling (GO:0010644) | 2.35349115 |
| 131 | transcytosis (GO:0045056) | 2.35191151 |
| 132 | mesenchymal to epithelial transition (GO:0060231) | 2.35132960 |
| 133 | cranial nerve structural organization (GO:0021604) | 2.34374325 |
| 134 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.34120779 |
| 135 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.29966147 |
| 136 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.29827360 |
| 137 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.29688479 |
| 138 | regulation of cellular respiration (GO:0043457) | 2.28585073 |
| 139 | sexual reproduction (GO:0019953) | 2.28263923 |
| 140 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.27603239 |
| 141 | dermatan sulfate biosynthetic process (GO:0030208) | 2.27560597 |
| 142 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.27454253 |
| 143 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.26896627 |
| 144 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.26459185 |
| 145 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.26459185 |
| 146 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.26150362 |
| 147 | midgut development (GO:0007494) | 2.25913192 |
| 148 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.24682732 |
| 149 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.24472529 |
| 150 | phosphate ion transmembrane transport (GO:0035435) | 2.24235776 |
| 151 | glomerulus development (GO:0032835) | 2.24154230 |
| 152 | positive regulation of hormone metabolic process (GO:0032352) | 2.24022306 |
| 153 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.23723694 |
| 154 | positive regulation of lipid catabolic process (GO:0050996) | 2.23549595 |
| 155 | drinking behavior (GO:0042756) | 2.23539666 |
| 156 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.21901026 |
| 157 | sodium ion homeostasis (GO:0055078) | 2.20910906 |
| 158 | nitrogen cycle metabolic process (GO:0071941) | 2.20821842 |
| 159 | cellular response to nitric oxide (GO:0071732) | 2.20472477 |
| 160 | cranial nerve morphogenesis (GO:0021602) | 2.20005637 |
| 161 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.18134033 |
| 162 | mannosylation (GO:0097502) | 2.17446763 |
| 163 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.16904806 |
| 164 | endocrine pancreas development (GO:0031018) | 2.14933630 |
| 165 | dermatan sulfate metabolic process (GO:0030205) | 2.13515719 |
| 166 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.13409380 |
| 167 | keratinocyte proliferation (GO:0043616) | 2.13203412 |
| 168 | nephron epithelium development (GO:0072009) | 2.12972184 |
| 169 | sulfation (GO:0051923) | 2.12589186 |
| 170 | peptide catabolic process (GO:0043171) | 2.10810951 |
| 171 | regulation of systemic arterial blood pressure (GO:0003073) | 2.10217084 |
| 172 | positive regulation of metanephros development (GO:0072216) | 2.09931659 |
| 173 | NADH metabolic process (GO:0006734) | 2.09891671 |
| 174 | central nervous system neuron axonogenesis (GO:0021955) | 2.08557514 |
| 175 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.08221741 |
| 176 | protein maturation by protein folding (GO:0022417) | 2.08055556 |
| 177 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.07592292 |
| 178 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.06889071 |
| 179 | short-term memory (GO:0007614) | 2.06772651 |
| 180 | COPII vesicle coating (GO:0048208) | 2.06366501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.23575831 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.65876074 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.06130529 |
| 4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.85657820 |
| 5 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65814147 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.46871721 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46389543 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46389543 |
| 9 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41483162 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.37354693 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.31290709 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30189592 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27380859 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24361405 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20483807 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.20171534 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19236362 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.17329195 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.15516288 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.13997277 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11151533 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09290615 |
| 23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.04569857 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.99528089 |
| 25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.98157646 |
| 26 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.92817992 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.92338257 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92332584 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.91862739 |
| 30 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90938565 |
| 31 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.80103151 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72752086 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.68994179 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.66498739 |
| 35 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64291096 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.63904190 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61987015 |
| 38 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.58935830 |
| 39 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57403526 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56744114 |
| 41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.53653404 |
| 42 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.52779757 |
| 43 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48481377 |
| 44 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.48229104 |
| 45 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47159633 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46894893 |
| 47 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46095892 |
| 48 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.42149998 |
| 49 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.40920614 |
| 50 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.38580197 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.37784567 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36416146 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.35250953 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34731595 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31852642 |
| 56 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.31675227 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30664623 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27026941 |
| 59 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24195962 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23806952 |
| 61 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23763641 |
| 62 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23685013 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22915867 |
| 64 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22152348 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20338554 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 1.18355764 |
| 67 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.16912651 |
| 68 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16855743 |
| 69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15905304 |
| 70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15905304 |
| 71 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.15790586 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15524809 |
| 73 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15409274 |
| 74 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13161369 |
| 75 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12893965 |
| 76 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12236224 |
| 77 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.11595869 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11561036 |
| 79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11475388 |
| 80 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.11088782 |
| 81 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11069495 |
| 82 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09954137 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.09743303 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07669369 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07397494 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07325628 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05643275 |
| 88 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.05368280 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05106745 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04950617 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04743329 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04716247 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04631632 |
| 94 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04482113 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04220979 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03901486 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02714975 |
| 98 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02619288 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01903057 |
| 100 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01051243 |
| 101 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00480804 |
| 102 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99676230 |
| 103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98391406 |
| 104 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97809722 |
| 105 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97455122 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97313669 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97224383 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96616976 |
| 109 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96464841 |
| 110 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95924187 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.95639823 |
| 112 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94889749 |
| 113 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94754846 |
| 114 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94032699 |
| 115 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93338438 |
| 116 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93168700 |
| 117 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91059981 |
| 118 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90341398 |
| 119 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.90326269 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.89821373 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89580420 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88852198 |
| 123 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.88835616 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88727108 |
| 125 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86507579 |
| 126 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84312629 |
| 127 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83983337 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83934148 |
| 129 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.83408866 |
| 130 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83116962 |
| 131 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82741603 |
| 132 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.82521875 |
| 133 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82188599 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82113616 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.80481752 |
| 136 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.79575288 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79104868 |
| 138 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79015043 |
| 139 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.78847810 |
| 140 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.78579224 |
| 141 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77625204 |
| 142 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.75572097 |
| 143 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.74402789 |
| 144 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73827293 |
| 145 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.73574113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.16600242 |
| 2 | MP0005360_urolithiasis | 3.36056481 |
| 3 | MP0002822_catalepsy | 3.26827837 |
| 4 | MP0003941_abnormal_skin_development | 2.95357039 |
| 5 | MP0001666_abnormal_nutrient_absorption | 2.89475296 |
| 6 | MP0004043_abnormal_pH_regulation | 2.50357013 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.48656763 |
| 8 | MP0000566_synostosis | 2.37868815 |
| 9 | MP0004270_analgesia | 2.37463343 |
| 10 | MP0004147_increased_porphyrin_level | 2.32925288 |
| 11 | MP0003283_abnormal_digestive_organ | 2.32214605 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.29228283 |
| 13 | MP0005084_abnormal_gallbladder_morpholo | 2.25693788 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.14888434 |
| 15 | MP0000462_abnormal_digestive_system | 2.04995563 |
| 16 | * MP0009379_abnormal_foot_pigmentation | 2.01608720 |
| 17 | MP0003385_abnormal_body_wall | 1.92848190 |
| 18 | MP0001958_emphysema | 1.91833014 |
| 19 | MP0004272_abnormal_basement_membrane | 1.90493066 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.90132550 |
| 21 | MP0001664_abnormal_digestion | 1.89648022 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.86841408 |
| 23 | MP0003879_abnormal_hair_cell | 1.81117316 |
| 24 | MP0009384_cardiac_valve_regurgitation | 1.77655321 |
| 25 | MP0005670_abnormal_white_adipose | 1.76593487 |
| 26 | MP0000751_myopathy | 1.76112708 |
| 27 | MP0001849_ear_inflammation | 1.74291326 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 1.73704856 |
| 29 | * MP0000049_abnormal_middle_ear | 1.71738029 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.67657572 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.65475228 |
| 32 | MP0002089_abnormal_postnatal_growth/wei | 1.62083995 |
| 33 | MP0002796_impaired_skin_barrier | 1.61894639 |
| 34 | MP0003279_aneurysm | 1.60860238 |
| 35 | * MP0000678_abnormal_parathyroid_gland | 1.58182411 |
| 36 | MP0003329_amyloid_beta_deposits | 1.57311996 |
| 37 | MP0005085_abnormal_gallbladder_physiolo | 1.52415787 |
| 38 | MP0005451_abnormal_body_composition | 1.51698243 |
| 39 | MP0000613_abnormal_salivary_gland | 1.48357200 |
| 40 | MP0003252_abnormal_bile_duct | 1.42938613 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.39531914 |
| 42 | MP0004858_abnormal_nervous_system | 1.39509535 |
| 43 | MP0003091_abnormal_cell_migration | 1.38401533 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.36657840 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.36036271 |
| 46 | MP0005023_abnormal_wound_healing | 1.35092215 |
| 47 | MP0008438_abnormal_cutaneous_collagen | 1.34530947 |
| 48 | MP0002751_abnormal_autonomic_nervous | 1.33690462 |
| 49 | * MP0001188_hyperpigmentation | 1.32594962 |
| 50 | MP0000538_abnormal_urinary_bladder | 1.32024703 |
| 51 | MP0000537_abnormal_urethra_morphology | 1.28052788 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.26961593 |
| 53 | MP0000534_abnormal_ureter_morphology | 1.23952692 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.23112129 |
| 55 | MP0002877_abnormal_melanocyte_morpholog | 1.22836252 |
| 56 | MP0009250_abnormal_appendicular_skeleto | 1.22679151 |
| 57 | MP0000467_abnormal_esophagus_morphology | 1.22354309 |
| 58 | MP0001944_abnormal_pancreas_morphology | 1.21836838 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21676961 |
| 60 | MP0005501_abnormal_skin_physiology | 1.20218183 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.19971430 |
| 62 | MP0003646_muscle_fatigue | 1.19257196 |
| 63 | MP0000762_abnormal_tongue_morphology | 1.18941418 |
| 64 | MP0003950_abnormal_plasma_membrane | 1.16697387 |
| 65 | MP0010329_abnormal_lipoprotein_level | 1.16217794 |
| 66 | MP0003868_abnormal_feces_composition | 1.15456645 |
| 67 | MP0002060_abnormal_skin_morphology | 1.11980975 |
| 68 | MP0003880_abnormal_central_pattern | 1.11963222 |
| 69 | MP0000477_abnormal_intestine_morphology | 1.11575896 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 1.10689065 |
| 71 | MP0003942_abnormal_urinary_system | 1.10286913 |
| 72 | MP0003119_abnormal_digestive_system | 1.10182950 |
| 73 | MP0002735_abnormal_chemical_nociception | 1.08683470 |
| 74 | MP0005503_abnormal_tendon_morphology | 1.08547697 |
| 75 | MP0005375_adipose_tissue_phenotype | 1.06601084 |
| 76 | MP0005666_abnormal_adipose_tissue | 1.06417292 |
| 77 | MP0010386_abnormal_urinary_bladder | 1.03530550 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 1.03285028 |
| 79 | MP0001270_distended_abdomen | 1.02596022 |
| 80 | MP0000631_abnormal_neuroendocrine_gland | 1.02058905 |
| 81 | MP0010368_abnormal_lymphatic_system | 1.00460939 |
| 82 | MP0000749_muscle_degeneration | 1.00437277 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.00158644 |
| 84 | MP0010030_abnormal_orbit_morphology | 0.99888627 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.99056550 |
| 86 | MP0000733_abnormal_muscle_development | 0.98373294 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.97623981 |
| 88 | MP0006138_congestive_heart_failure | 0.96804837 |
| 89 | MP0000579_abnormal_nail_morphology | 0.96782795 |
| 90 | MP0005508_abnormal_skeleton_morphology | 0.96375175 |
| 91 | * MP0000230_abnormal_systemic_arterial | 0.94832760 |
| 92 | MP0002295_abnormal_pulmonary_circulatio | 0.94633488 |
| 93 | MP0003183_abnormal_peptide_metabolism | 0.92900464 |
| 94 | MP0001663_abnormal_digestive_system | 0.90424599 |
| 95 | MP0002557_abnormal_social/conspecific_i | 0.90211606 |
| 96 | MP0003866_abnormal_defecation | 0.89733057 |
| 97 | MP0000747_muscle_weakness | 0.89671682 |
| 98 | MP0005165_increased_susceptibility_to | 0.88936916 |
| 99 | MP0002733_abnormal_thermal_nociception | 0.87341812 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.86706452 |
| 101 | * MP0009643_abnormal_urine_homeostasis | 0.84394486 |
| 102 | MP0001177_atelectasis | 0.83740820 |
| 103 | MP0002971_abnormal_brown_adipose | 0.83631911 |
| 104 | MP0005448_abnormal_energy_balance | 0.83404118 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.83040712 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.82872346 |
| 107 | MP0005365_abnormal_bile_salt | 0.82191137 |
| 108 | MP0010155_abnormal_intestine_physiology | 0.81718609 |
| 109 | MP0009697_abnormal_copulation | 0.81676605 |
| 110 | MP0005330_cardiomyopathy | 0.81490902 |
| 111 | MP0003136_yellow_coat_color | 0.81039514 |
| 112 | MP0001756_abnormal_urination | 0.80684896 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.80251641 |
| 114 | * MP0002249_abnormal_larynx_morphology | 0.79835297 |
| 115 | * MP0001765_abnormal_ion_homeostasis | 0.79687444 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.78791016 |
| 117 | * MP0002177_abnormal_outer_ear | 0.78719172 |
| 118 | * MP0000681_abnormal_thyroid_gland | 0.78363078 |
| 119 | MP0003878_abnormal_ear_physiology | 0.78303502 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.78303502 |
| 121 | * MP0002734_abnormal_mechanical_nocicepti | 0.78258392 |
| 122 | MP0001968_abnormal_touch/_nociception | 0.78055344 |
| 123 | MP0006054_spinal_hemorrhage | 0.77437641 |
| 124 | MP0002160_abnormal_reproductive_system | 0.75070422 |
| 125 | MP0006276_abnormal_autonomic_nervous | 0.74810899 |
| 126 | MP0008569_lethality_at_weaning | 0.73298684 |
| 127 | * MP0002896_abnormal_bone_mineralization | 0.72851701 |
| 128 | MP0005332_abnormal_amino_acid | 0.72808163 |
| 129 | MP0000759_abnormal_skeletal_muscle | 0.72630160 |
| 130 | MP0000163_abnormal_cartilage_morphology | 0.71916914 |
| 131 | MP0003122_maternal_imprinting | 0.71654220 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.71402554 |
| 133 | MP0004087_abnormal_muscle_fiber | 0.71301114 |
| 134 | MP0000490_abnormal_crypts_of | 0.70942143 |
| 135 | MP0004085_abnormal_heartbeat | 0.70495433 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.68784911 |
| 137 | MP0003828_pulmonary_edema | 0.68520498 |
| 138 | MP0006292_abnormal_olfactory_placode | 0.68193270 |
| 139 | MP0005275_abnormal_skin_tensile | 0.67704092 |
| 140 | MP0003959_abnormal_lean_body | 0.67248817 |
| 141 | MP0001919_abnormal_reproductive_system | 0.67037863 |
| 142 | MP0010234_abnormal_vibrissa_follicle | 0.66701873 |
| 143 | MP0009840_abnormal_foam_cell | 0.66619311 |
| 144 | MP0002184_abnormal_innervation | 0.66340119 |
| 145 | MP0002108_abnormal_muscle_morphology | 0.64192255 |
| 146 | MP0001216_abnormal_epidermal_layer | 0.63912043 |
| 147 | MP0001879_abnormal_lymphatic_vessel | 0.62978677 |
| 148 | MP0003045_fibrosis | 0.62874033 |
| 149 | MP0001299_abnormal_eye_distance/ | 0.62085905 |
| 150 | MP0010771_integument_phenotype | 0.60850814 |
| 151 | MP0002932_abnormal_joint_morphology | 0.56854602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I transferrin isoform profile (HP:0003642) | 5.16485308 |
| 2 | Reduced antithrombin III activity (HP:0001976) | 4.81957687 |
| 3 | Ileus (HP:0002595) | 4.65545788 |
| 4 | Abnormal protein glycosylation (HP:0012346) | 3.94207917 |
| 5 | Abnormal glycosylation (HP:0012345) | 3.94207917 |
| 6 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.94207917 |
| 7 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.94207917 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 3.62912651 |
| 9 | Aplasia/hypoplasia of the uterus (HP:0008684) | 3.50858471 |
| 10 | Late onset (HP:0003584) | 3.35385676 |
| 11 | Thin bony cortex (HP:0002753) | 3.12676111 |
| 12 | Obstructive sleep apnea (HP:0002870) | 3.07642502 |
| 13 | Type 1 muscle fiber predominance (HP:0003803) | 2.95074560 |
| 14 | Spinal rigidity (HP:0003306) | 2.92924681 |
| 15 | Shallow orbits (HP:0000586) | 2.92311291 |
| 16 | Hepatic necrosis (HP:0002605) | 2.89963149 |
| 17 | Malnutrition (HP:0004395) | 2.86305651 |
| 18 | Cerebral aneurysm (HP:0004944) | 2.83464468 |
| 19 | Bradycardia (HP:0001662) | 2.80488047 |
| 20 | Hyperactive renin-angiotensin system (HP:0000841) | 2.75869083 |
| 21 | Vascular tortuosity (HP:0004948) | 2.75504220 |
| 22 | Upper limb amyotrophy (HP:0009129) | 2.72723736 |
| 23 | Distal upper limb amyotrophy (HP:0007149) | 2.72723736 |
| 24 | Popliteal pterygium (HP:0009756) | 2.72459552 |
| 25 | Increased connective tissue (HP:0009025) | 2.71488474 |
| 26 | Distal lower limb amyotrophy (HP:0008944) | 2.71166545 |
| 27 | Flat acetabular roof (HP:0003180) | 2.70440770 |
| 28 | Abnormal sex determination (HP:0012244) | 2.69757825 |
| 29 | Sex reversal (HP:0012245) | 2.69757825 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.67761606 |
| 31 | Aortic dissection (HP:0002647) | 2.66785814 |
| 32 | Aortic aneurysm (HP:0004942) | 2.65046176 |
| 33 | Neonatal short-limb short stature (HP:0008921) | 2.64700286 |
| 34 | Arterial tortuosity (HP:0005116) | 2.63083442 |
| 35 | Split foot (HP:0001839) | 2.62622236 |
| 36 | Glycosuria (HP:0003076) | 2.58449404 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 2.58449404 |
| 38 | Hypoplasia of the uterus (HP:0000013) | 2.55578039 |
| 39 | Broad metatarsal (HP:0001783) | 2.54879319 |
| 40 | Distal lower limb muscle weakness (HP:0009053) | 2.54521625 |
| 41 | Hypothermia (HP:0002045) | 2.54459096 |
| 42 | Congenital sensorineural hearing impairment (HP:0008527) | 2.54190994 |
| 43 | Hepatocellular necrosis (HP:0001404) | 2.52646915 |
| 44 | Bladder diverticulum (HP:0000015) | 2.52581307 |
| 45 | Hypoglycemic coma (HP:0001325) | 2.52432958 |
| 46 | Ankle contracture (HP:0006466) | 2.50805243 |
| 47 | Abdominal distention (HP:0003270) | 2.48965856 |
| 48 | Unilateral renal agenesis (HP:0000122) | 2.47518093 |
| 49 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45096300 |
| 50 | Hyperglycinuria (HP:0003108) | 2.43133883 |
| 51 | Cervical subluxation (HP:0003308) | 2.42359645 |
| 52 | Wormian bones (HP:0002645) | 2.42357959 |
| 53 | Polygenic inheritance (HP:0010982) | 2.40872509 |
| 54 | Cortical visual impairment (HP:0100704) | 2.39123043 |
| 55 | Cutaneous finger syndactyly (HP:0010554) | 2.36519376 |
| 56 | Hyperacusis (HP:0010780) | 2.35941189 |
| 57 | Stridor (HP:0010307) | 2.34403524 |
| 58 | Myokymia (HP:0002411) | 2.30143786 |
| 59 | Ulnar bowing (HP:0003031) | 2.28909624 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.28727676 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.26902678 |
| 62 | Mesangial abnormality (HP:0001966) | 2.26670768 |
| 63 | Spinal cord compression (HP:0002176) | 2.22417657 |
| 64 | Decreased circulating renin level (HP:0003351) | 2.22340884 |
| 65 | Myopathic facies (HP:0002058) | 2.20277646 |
| 66 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18607879 |
| 67 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.18549833 |
| 68 | Hyperphosphaturia (HP:0003109) | 2.17923480 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.17546894 |
| 70 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.16966634 |
| 71 | Lower limb amyotrophy (HP:0007210) | 2.16121227 |
| 72 | Abnormality of vitamin B metabolism (HP:0004340) | 2.15899678 |
| 73 | * Hyperparathyroidism (HP:0000843) | 2.13336185 |
| 74 | Hemorrhage of the eye (HP:0011885) | 2.12900565 |
| 75 | Abnormality of carpal bone ossification (HP:0006257) | 2.09657194 |
| 76 | Prolonged QT interval (HP:0001657) | 2.09507441 |
| 77 | Aneurysm (HP:0002617) | 2.09205021 |
| 78 | Protrusio acetabuli (HP:0003179) | 2.08954368 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 2.08840593 |
| 80 | Broad face (HP:0000283) | 2.08333493 |
| 81 | Syncope (HP:0001279) | 2.06983589 |
| 82 | Hyperaldosteronism (HP:0000859) | 2.06622067 |
| 83 | Genu recurvatum (HP:0002816) | 2.06376183 |
| 84 | Palpitations (HP:0001962) | 2.05660962 |
| 85 | Hypoventilation (HP:0002791) | 2.05580412 |
| 86 | Short nail (HP:0001799) | 2.02952836 |
| 87 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.02522422 |
| 88 | Bronchomalacia (HP:0002780) | 2.02210903 |
| 89 | Hyperextensible skin (HP:0000974) | 2.02198185 |
| 90 | Symptomatic seizures (HP:0011145) | 2.02164201 |
| 91 | Blue sclerae (HP:0000592) | 2.01812231 |
| 92 | Knee flexion contracture (HP:0006380) | 2.00951296 |
| 93 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.99993601 |
| 94 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.99523234 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 1.97918249 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97918249 |
| 97 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.96489916 |
| 98 | Mitral regurgitation (HP:0001653) | 1.95619276 |
| 99 | Abnormal ossification of hand bones (HP:0005921) | 1.95362549 |
| 100 | Metabolic alkalosis (HP:0200114) | 1.94688547 |
| 101 | Cutaneous syndactyly (HP:0012725) | 1.94584039 |
| 102 | Abnormality of the aortic arch (HP:0012303) | 1.94204792 |
| 103 | Agitation (HP:0000713) | 1.94087717 |
| 104 | Annular pancreas (HP:0001734) | 1.93570888 |
| 105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.93333792 |
| 106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93037568 |
| 107 | Ketoacidosis (HP:0001993) | 1.92437389 |
| 108 | Gastrointestinal dysmotility (HP:0002579) | 1.92394488 |
| 109 | Hand muscle atrophy (HP:0009130) | 1.90963090 |
| 110 | Disproportionate tall stature (HP:0001519) | 1.90826348 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 1.90764772 |
| 112 | Hydroxyprolinuria (HP:0003080) | 1.90764772 |
| 113 | Focal segmental glomerulosclerosis (HP:0000097) | 1.90403314 |
| 114 | Confusion (HP:0001289) | 1.90234458 |
| 115 | Pterygium (HP:0001059) | 1.90198462 |
| 116 | Fat malabsorption (HP:0002630) | 1.89449102 |
| 117 | Sleep apnea (HP:0010535) | 1.89273875 |
| 118 | Bundle branch block (HP:0011710) | 1.87198970 |
| 119 | Abnormal urine phosphate concentration (HP:0012599) | 1.87023634 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.85404540 |
| 121 | Abnormality of chloride homeostasis (HP:0011422) | 1.85243465 |
| 122 | Soft skin (HP:0000977) | 1.85072288 |
| 123 | Proximal tubulopathy (HP:0000114) | 1.83495368 |
| 124 | Round ear (HP:0100830) | 1.83167119 |
| 125 | Nonprogressive disorder (HP:0003680) | 1.82944459 |
| 126 | Abnormality of renin-angiotensin system (HP:0000847) | 1.82675993 |
| 127 | True hermaphroditism (HP:0010459) | 1.82551963 |
| 128 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.81470401 |
| 129 | Growth hormone excess (HP:0000845) | 1.81186577 |
| 130 | Thyroid-stimulating hormone excess (HP:0002925) | 1.80536770 |
| 131 | Difficulty climbing stairs (HP:0003551) | 1.80526962 |
| 132 | Renal Fanconi syndrome (HP:0001994) | 1.79724116 |
| 133 | Wide cranial sutures (HP:0010537) | 1.79287070 |
| 134 | Hypobetalipoproteinemia (HP:0003563) | 1.79052476 |
| 135 | Tibial bowing (HP:0002982) | 1.78317273 |
| 136 | Coxa vara (HP:0002812) | 1.77589611 |
| 137 | Xanthomatosis (HP:0000991) | 1.77343681 |
| 138 | Congenital glaucoma (HP:0001087) | 1.76755507 |
| 139 | Hypokalemia (HP:0002900) | 1.76327188 |
| 140 | Adrenal overactivity (HP:0002717) | 1.75341741 |
| 141 | Mitral valve prolapse (HP:0001634) | 1.74767205 |
| 142 | Insulin resistance (HP:0000855) | 1.74120209 |
| 143 | Atrophic scars (HP:0001075) | 1.73650758 |
| 144 | Abnormality of dentin (HP:0010299) | 1.73281461 |
| 145 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73266352 |
| 146 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72882238 |
| 147 | Dicarboxylic aciduria (HP:0003215) | 1.72882238 |
| 148 | Hypoglycemic seizures (HP:0002173) | 1.72548706 |
| 149 | Goiter (HP:0000853) | 1.72425515 |
| 150 | Hoarse voice (HP:0001609) | 1.72150591 |
| 151 | Fragile skin (HP:0001030) | 1.71876009 |
| 152 | Cardiovascular calcification (HP:0011915) | 1.71558441 |
| 153 | Exercise-induced myalgia (HP:0003738) | 1.70842221 |
| 154 | Neonatal death (HP:0003811) | 1.70321395 |
| 155 | Acanthosis nigricans (HP:0000956) | 1.70123904 |
| 156 | Dilatation of the ascending aorta (HP:0005111) | 1.69550778 |
| 157 | Ventricular fibrillation (HP:0001663) | 1.67551337 |
| 158 | Follicular hyperkeratosis (HP:0007502) | 1.67038562 |
| 159 | Turricephaly (HP:0000262) | 1.65104207 |
| 160 | Conjugated hyperbilirubinemia (HP:0002908) | 1.65059977 |
| 161 | Abnormality of complement system (HP:0005339) | 1.64086042 |
| 162 | Germ cell neoplasia (HP:0100728) | 1.63517920 |
| 163 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.63168670 |
| 164 | Systemic lupus erythematosus (HP:0002725) | 1.63163557 |
| 165 | Widely patent fontanelles and sutures (HP:0004492) | 1.63027363 |
| 166 | Elbow flexion contracture (HP:0002987) | 1.62056936 |
| 167 | Joint laxity (HP:0001388) | 1.61616860 |
| 168 | Hypercortisolism (HP:0001578) | 1.60319958 |
| 169 | Skin nodule (HP:0200036) | 1.60214916 |
| 170 | Abnormality of the nasal mucosa (HP:0000433) | 1.60047201 |
| 171 | Visual hallucinations (HP:0002367) | 1.59165137 |
| 172 | Abnormality of the acetabulum (HP:0003170) | 1.59072121 |
| 173 | Rectal prolapse (HP:0002035) | 1.58839374 |
| 174 | Abnormality of glycine metabolism (HP:0010895) | 1.58746128 |
| 175 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.58746128 |
| 176 | Asymmetric growth (HP:0100555) | 1.58219594 |
| 177 | Neurofibrillary tangles (HP:0002185) | 1.57892512 |
| 178 | Premature rupture of membranes (HP:0001788) | 1.57827356 |
| 179 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.56107811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 5.98232487 |
| 2 | EIF2AK3 | 3.17936676 |
| 3 | CASK | 3.10287566 |
| 4 | LMTK2 | 2.92998772 |
| 5 | NLK | 2.57033439 |
| 6 | FRK | 2.36279173 |
| 7 | EPHB2 | 2.29609296 |
| 8 | TTN | 2.23972283 |
| 9 | SIK1 | 2.17224708 |
| 10 | PRKG2 | 2.16520810 |
| 11 | ICK | 2.12377412 |
| 12 | MYLK | 2.09923580 |
| 13 | MAP2K2 | 2.08191471 |
| 14 | MUSK | 2.07266863 |
| 15 | EEF2K | 2.06516468 |
| 16 | BCKDK | 2.05637629 |
| 17 | SMG1 | 2.04073508 |
| 18 | NTRK3 | 1.97963336 |
| 19 | CAMKK2 | 1.92250382 |
| 20 | FER | 1.89737659 |
| 21 | MST1R | 1.86724307 |
| 22 | MAP3K2 | 1.85417191 |
| 23 | MAP2K7 | 1.74603989 |
| 24 | WNK4 | 1.65679218 |
| 25 | NME1 | 1.60236060 |
| 26 | AKT3 | 1.58681300 |
| 27 | MARK1 | 1.54292956 |
| 28 | MET | 1.45577516 |
| 29 | CAMKK1 | 1.43239984 |
| 30 | FGFR4 | 1.37076569 |
| 31 | EPHA4 | 1.35138904 |
| 32 | MKNK2 | 1.33766743 |
| 33 | RIPK1 | 1.29060887 |
| 34 | EPHB1 | 1.29032165 |
| 35 | NTRK1 | 1.28409377 |
| 36 | PAK4 | 1.26719921 |
| 37 | MAP3K10 | 1.25393407 |
| 38 | INSRR | 1.23359650 |
| 39 | PKN2 | 1.20121330 |
| 40 | DDR2 | 1.16725777 |
| 41 | CAMK1 | 1.11110538 |
| 42 | MAPK15 | 1.11091343 |
| 43 | KSR2 | 1.08413826 |
| 44 | TRIB3 | 1.03546213 |
| 45 | PHKG1 | 1.03328146 |
| 46 | PHKG2 | 1.03328146 |
| 47 | PIK3CA | 1.02924341 |
| 48 | MAP3K1 | 1.01875642 |
| 49 | ARAF | 1.01064320 |
| 50 | PAK3 | 1.00880084 |
| 51 | IRAK3 | 0.97148583 |
| 52 | TIE1 | 0.94068553 |
| 53 | EPHA2 | 0.93363922 |
| 54 | ACVR1B | 0.93354270 |
| 55 | MAPKAPK3 | 0.92115498 |
| 56 | PDPK1 | 0.91350497 |
| 57 | TAOK1 | 0.90750301 |
| 58 | PRKCI | 0.89410199 |
| 59 | ROCK1 | 0.88725141 |
| 60 | MTOR | 0.88550619 |
| 61 | PAK6 | 0.87559762 |
| 62 | PRKD3 | 0.86731309 |
| 63 | PTK2B | 0.86480203 |
| 64 | EIF2AK2 | 0.85544549 |
| 65 | TESK1 | 0.84151138 |
| 66 | STK38 | 0.83241818 |
| 67 | MAP2K1 | 0.81301620 |
| 68 | ABL2 | 0.78409599 |
| 69 | LATS2 | 0.77858259 |
| 70 | PINK1 | 0.76946308 |
| 71 | CAMK2D | 0.76530609 |
| 72 | PIM2 | 0.75810591 |
| 73 | DMPK | 0.75537284 |
| 74 | LIMK1 | 0.73017761 |
| 75 | MINK1 | 0.72709654 |
| 76 | DAPK2 | 0.71005416 |
| 77 | CDC42BPA | 0.70413873 |
| 78 | CDK12 | 0.70285698 |
| 79 | ERN1 | 0.70089453 |
| 80 | PTK2 | 0.69778863 |
| 81 | CAMK2B | 0.69449237 |
| 82 | MAP3K6 | 0.68650103 |
| 83 | PDGFRA | 0.67176839 |
| 84 | MAP3K7 | 0.66608302 |
| 85 | ROCK2 | 0.63092572 |
| 86 | ERBB2 | 0.63090749 |
| 87 | MAP3K9 | 0.62573823 |
| 88 | TESK2 | 0.62447008 |
| 89 | STK16 | 0.61418388 |
| 90 | PRPF4B | 0.60740308 |
| 91 | CAMK4 | 0.60368201 |
| 92 | FES | 0.60346499 |
| 93 | MAP2K6 | 0.59509145 |
| 94 | LATS1 | 0.58990586 |
| 95 | BRAF | 0.58980398 |
| 96 | ZAK | 0.57940338 |
| 97 | CDK19 | 0.57370433 |
| 98 | UHMK1 | 0.57349206 |
| 99 | CAMK2A | 0.57038552 |
| 100 | MAP3K11 | 0.56625661 |
| 101 | PDGFRB | 0.56095367 |
| 102 | MAPK11 | 0.55623740 |
| 103 | NEK6 | 0.54212937 |
| 104 | CDK5 | 0.53647361 |
| 105 | RET | 0.53271282 |
| 106 | TYRO3 | 0.51745487 |
| 107 | MST4 | 0.51080662 |
| 108 | PRKD2 | 0.50933857 |
| 109 | DYRK1B | 0.50603921 |
| 110 | PTK6 | 0.50245980 |
| 111 | CAMK2G | 0.48550323 |
| 112 | GRK1 | 0.47865532 |
| 113 | PAK2 | 0.47454037 |
| 114 | DAPK3 | 0.47191185 |
| 115 | MAP3K8 | 0.47154035 |
| 116 | BMX | 0.45656201 |
| 117 | MARK2 | 0.43107703 |
| 118 | MAP3K3 | 0.43006847 |
| 119 | PRKCG | 0.42144350 |
| 120 | TGFBR2 | 0.41670545 |
| 121 | SRPK1 | 0.41493624 |
| 122 | AKT2 | 0.41449162 |
| 123 | MAPK13 | 0.40962216 |
| 124 | DYRK2 | 0.40222136 |
| 125 | LRRK2 | 0.38950399 |
| 126 | PRKCE | 0.38081939 |
| 127 | SCYL2 | 0.37544575 |
| 128 | RPS6KA2 | 0.37359523 |
| 129 | SRC | 0.36421528 |
| 130 | SGK494 | 0.35682963 |
| 131 | SGK223 | 0.35682963 |
| 132 | MOS | 0.35417007 |
| 133 | STK39 | 0.35229856 |
| 134 | CDK11A | 0.34617330 |
| 135 | ERBB4 | 0.34536582 |
| 136 | RPS6KL1 | 0.34200906 |
| 137 | RPS6KC1 | 0.34200906 |
| 138 | CDK15 | 0.33582548 |
| 139 | KDR | 0.33423012 |
| 140 | MAP3K12 | 0.33396553 |
| 141 | PRKAA2 | 0.33250815 |
| 142 | TLK1 | 0.31763890 |
| 143 | ILK | 0.31430806 |
| 144 | TAOK2 | 0.28571075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.68455861 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.45125093 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.11870488 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.82963267 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.54796884 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.52167118 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.30600679 |
| 8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.22913429 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.11969191 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 2.07863349 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.99185101 |
| 12 | Protein export_Homo sapiens_hsa03060 | 1.98107750 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.92905211 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.92699193 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 1.77330358 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75575769 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.74494120 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.54811707 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38627265 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.37371360 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.37097118 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.36204236 |
| 23 | * Insulin secretion_Homo sapiens_hsa04911 | 1.35080696 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34422393 |
| 25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29902689 |
| 26 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.23937023 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.16840923 |
| 28 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15634920 |
| 29 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.15600454 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.12363498 |
| 31 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.11852692 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11801710 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09346891 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.07847325 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06054189 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99208137 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98662169 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.98451894 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96573835 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 0.96057613 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94990235 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94683435 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92836489 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92641202 |
| 45 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91471465 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91118828 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90583872 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89763493 |
| 49 | Circadian entrainment_Homo sapiens_hsa04713 | 0.89057370 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 0.88508888 |
| 51 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.88313046 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88079725 |
| 53 | Tight junction_Homo sapiens_hsa04530 | 0.87748346 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87687935 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87687111 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87491707 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87275602 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.86240659 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86225985 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85121268 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83408597 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83407315 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.81063252 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.80856185 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80024923 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79427942 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78854866 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78165679 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77363700 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77313253 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76778749 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74371358 |
| 73 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74324991 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72233100 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.70349931 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.70266019 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.70147498 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69952206 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69816550 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69640580 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69636442 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68408441 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68371476 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.67473030 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66960949 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66810704 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66697228 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66042006 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64998965 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63689138 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63631432 |
| 92 | * Cholinergic synapse_Homo sapiens_hsa04725 | 0.63468820 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.63386915 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62991108 |
| 95 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62768806 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62507884 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61513328 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61002536 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.58928114 |
| 100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.58480398 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57995375 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57355799 |
| 103 | * Amoebiasis_Homo sapiens_hsa05146 | 0.57292511 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56825661 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56503701 |
| 106 | Axon guidance_Homo sapiens_hsa04360 | 0.55365226 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55252504 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.54960726 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54172872 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.52458682 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51684544 |
| 112 | * Gap junction_Homo sapiens_hsa04540 | 0.51677315 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51630792 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51370176 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.51287217 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51084824 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51083072 |
| 118 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.50828236 |
| 119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48752119 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48387826 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47593936 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47178869 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46703199 |
| 124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45370210 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45201744 |
| 126 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44845960 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44268681 |
| 128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44258825 |
| 129 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43836463 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.43462268 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42631340 |
| 132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41194828 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40894718 |
| 134 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40467069 |
| 135 | * Long-term depression_Homo sapiens_hsa04730 | 0.39843771 |
| 136 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38571646 |
| 137 | GABAergic synapse_Homo sapiens_hsa04727 | 0.38475565 |
| 138 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38283057 |
| 139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37754454 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37643531 |

